Selinexor for the treatment of multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selinexor for the treatment of multiple myeloma

Published:2020-01-19 Issue:4 Volume:21 Page:399-408
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Podar Klaus¹,Shah Jatin²,Chari Ajai³,Richardson Paul G⁴,Jagannath Sundar²

Affiliation:

1. Department of Internal Medicine, Karl Landsteiner University of Health Sciences, University Hospital, Krems, Austria

2. Karyopharm Therapeutics, Newton, MA, USA

3. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

4. Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1707184

Reference98 articles.

1. Nucleo-cytoplasmic transport as a therapeutic target of cancer

2. The Oncogene eIF4E Reprograms the Nuclear Pore Complex to Promote mRNA Export and Oncogenic Transformation

3. Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling

4. Selective inhibitors of nuclear export (SINE) in hematological malignancies

5. CRM1-mediated nuclear export: to the pore and beyond

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib;Cell Death & Disease;2024-08-13

2. Rediscovering hemostasis abnormalities in multiple myeloma: The new era;Heliyon;2024-07

3. Novel Anti-Enterovirus A71 Compounds Discovered by Repositioning Antivirals from the Open-Source MMV Pandemic Response Box;Pharmaceuticals;2024-06-14

4. The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines;Archives of Dermatological Research;2024-06-01

5. Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy;Frontiers in Medicine;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3